BCAX vs BTGO
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BCAX · Bicara Therapeutics$8.65 ▲ 5.62%
BTGO · BitGo Holdings$4.86 ▲ 2.10%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BCAX -49.0%
- BTGO -73.0%
Head to head
| Metric | BCAX | BTGO |
|---|---|---|
| Price | $8.65 | $4.86 |
| Change today | ▲ 5.62% | ▲ 2.10% |
| Market cap | $572.40M | $571.27M |
| Return, 3 months | -68.8% | -3.4% |
| Return, year to date | -48.6% | – |
| Return, 1 year | -40.9% | – |
| P/E (TTM) | – | – |
| P/B | 1.2 | 1.4 |
| P/E percentile vs own 5y | 99th | 54th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +79.6% |
| Net profit growth (YoY) | -102.4% | -149.7% |
| Gross margin | – | 1.0% |
| Operating margin | – | -0.1% |
| Net margin | – | -0.5% |
| Return on equity | -41.0% | -39.6% |
| Analyst target vs. price | +283.1% | +133.1% |
| Analyst buy share | 86% | 90% |
| RSI (14) | 24 | 34 |
| 30-day volatility | 182.7% | 73.4% |
| Max drawdown, 1 year | -73.9% | -74.6% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BCAX is the largest of the group by market value.
- BTGO has been the calmest stock over the last 30 days.